Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use.
anxiety
cannabis use
cannabis use disorder
depression
self-medication
withdrawal symptoms
young adults
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
07 02 2022
07 02 2022
Historique:
received:
15
12
2021
revised:
02
02
2022
accepted:
05
02
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Using cannabis to reduce psychological and physical distress, referred to as self-medication, is a significant risk factor for cannabis use disorder. To better understand this high-risk behavior, a sample of 290 young adults (ages 18-25; 45.6% female) were recruited from two U.S. universities in January and February of 2020 to complete a survey about their cannabis use and self-medication. Results: seventy-six percent endorsed using cannabis to reduce problems such as anxiety, sleep, depression, pain, loneliness, social discomfort, and concentration. When predicting reasons for self-medication with cannabis, logistic regression models showed that lower CUDIT-R scores, experiencing withdrawal, living in a state where cannabis was illegal, and being female were all associated with higher rates of self-medication. Withdrawal symptoms were tested to predict self-medication with cannabis, and only insomnia and loss of appetite were significant predictors. To further explore why young adults self-medicate, each of the original predictors were regressed on seven specified reasons for self-medication. Young adults experiencing withdrawal were more likely to self-medicate for pain. Participants living where cannabis is legal were less likely to self-medicate for anxiety and depression. Living where cannabis is illegal also significantly predicted self-medicating for social discomfort-though the overall model predicting social discomfort was statistically non-significant. Finally, female participants were more likely to self-medicate for anxiety. These results suggest widespread self-medication among young adults with likely CUD and underscore the complexity of their cannabis use. The findings have implications for understanding why young adults use cannabis in relation to psychological and physical distress and for accurately treating young adults with cannabis use disorder.
Identifiants
pubmed: 35162872
pii: ijerph19031850
doi: 10.3390/ijerph19031850
pmc: PMC8834899
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : R01 DA044206
Pays : United States
Références
Behav Sleep Med. 2019 May-Jun;17(3):327-341
pubmed: 28749704
Am J Drug Alcohol Abuse. 2017 Jul;43(4):442-455
pubmed: 27612527
JAMA Netw Open. 2020 Apr 1;3(4):e202370
pubmed: 32271390
Front Psychiatry. 2020 Mar 17;11:114
pubmed: 32256392
Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43
pubmed: 20347232
Addict Behav. 2009 Sep;34(9):764-8
pubmed: 19497678
Depress Anxiety. 2008;25(10):862-73
pubmed: 17849459
Curr Neuropharmacol. 2014 Sep;12(5):462-74
pubmed: 25426013
J Stud Alcohol Drugs. 2016 Nov;77(6):881-888
pubmed: 27797689
Soc Sci Med. 2019 Jul;233:181-192
pubmed: 31207470
Drug Alcohol Depend. 2014 Jun 1;139:41-6
pubmed: 24685559
J Subst Abuse Treat. 2009 Jun;36(4):400-13
pubmed: 19004601
Addict Behav. 2007 Jan;32(1):49-62
pubmed: 16647822
Addict Behav. 2017 Sep;72:14-20
pubmed: 28340421
Psychol Addict Behav. 2015 Sep;29(3):627-32
pubmed: 25915689
Eur Neuropsychopharmacol. 2016 Mar;26(3):493-505
pubmed: 26775742
Clin Pract Epidemiol Ment Health. 2007 Nov 19;3:25
pubmed: 18021439
Subst Use Misuse. 2014 Mar;49(4):427-34
pubmed: 24093525
Am J Addict. 2006 Jan-Feb;15(1):8-14
pubmed: 16449088
PLoS One. 2012;7(9):e44864
pubmed: 23049760
J Altern Complement Med. 2019 Mar;25(3):326-335
pubmed: 30383388
J Health Care Poor Underserved. 2017;28(2S):113-131
pubmed: 28458268
Subst Use Misuse. 2008;43(11):1653-65
pubmed: 18752166
Isr J Psychiatry Relat Sci. 2014;51(4):270-5
pubmed: 25841223
Drug Alcohol Depend. 2018 May 1;186:10-15
pubmed: 29525698
Subst Use Misuse. 2008;43(3-4):429-44
pubmed: 18365942
Subst Use Misuse. 2016 Sep 18;51(11):1504-11
pubmed: 27356272
Health Aff (Millwood). 2016 Jul 1;35(7):1230-6
pubmed: 27385238
J Drug Issues. 2009;39(3):677-714
pubmed: 20628558
Addict Behav. 2007 Aug;32(8):1537-45
pubmed: 17178197
Subst Abuse Rehabil. 2017 Apr 27;8:9-37
pubmed: 28490916
Eur Neuropsychopharmacol. 2017 Aug;27(8):795-808
pubmed: 28576350
J Youth Adolesc. 2018 Aug;47(8):1755-1770
pubmed: 29774451
Harm Reduct J. 2005 Sep 22;2:17
pubmed: 16179090
J Stud Alcohol Drugs. 2013 Sep;74(5):720-6
pubmed: 23948531
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):160-166
pubmed: 28861516
J Psychoactive Drugs. 2015 Nov-Dec;47(5):345-50
pubmed: 26595140
Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
pubmed: 9385000
Pharmacopsychiatry. 2008 Mar;41(2):48-53
pubmed: 18311684
J Neuroimmune Pharmacol. 2018 Dec;13(4):438-452
pubmed: 29556883
J Affect Disord. 2015 Feb 1;172:211-8
pubmed: 25451420
J Stud Alcohol Drugs. 2016 Mar;77(2):287-97
pubmed: 26997187
Am J Psychiatry. 1985 Nov;142(11):1259-64
pubmed: 3904487
Dev Psychopathol. 2013 Nov;25(4 Pt 2):1567-84
pubmed: 24342856
Addict Behav. 2017 Sep;72:159-164
pubmed: 28453999
Prev Med. 2017 Nov;104:13-23
pubmed: 28705601
Drug Alcohol Depend. 2012 Oct 1;125(3):267-75
pubmed: 22464050
BMC Psychiatry. 2020 Jan 16;20(1):24
pubmed: 31948424
J Gen Intern Med. 2016 May;31(5):486-91
pubmed: 26809204
Int J Drug Policy. 2022 Feb;100:103517
pubmed: 34894469
Front Psychiatry. 2014 Nov 24;5:168
pubmed: 25505428